Oral testosterone for menopausal women with low sexual desire
Part of Mental health clinical trials.
This trial tests a daily oral testosterone capsule (Kyzatrex) for menopausal women with low sexual desire and low testosterone. You would take the medication for several weeks and be monitored for changes in sexual desire and safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 30 or older who is in menopause.
- You have been diagnosed with low sexual desire (hypoactive sexual desire disorder).
- Your testosterone level is below 30 ng/dL (a blood test will confirm).
- Your body mass index (BMI) is 34 or lower.
- You have had a normal Pap smear and mammogram within the last 6 months (if applicable).
- You have not used testosterone treatments in the past 4 weeks (or 6 months for pellets).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called bupropion can help women with hormone receptor-positive breast cancer who are taking aromatase inhibitors (drugs that block estrogen) but experiencing low sexual desire as a side effect. The goal is to see if this approach improves both tolerance to the cancer medication and quality of life.
This trial tests a new drug called Leflutrozole to see if it can improve testicular function in men with low testosterone and low sperm count. The goal is to help increase natural hormone levels and sperm production.
This study tests a testosterone gel applied to the skin to see if it helps women in perimenopause or postmenopause who have low sexual interest and arousal. It aims to find a new treatment option for this condition.
This study tests whether taking testosterone can improve erectile function and sexual desire in men with multiple sclerosis (MS) who have low testosterone. You may be screened with blood tests, questionnaires, and regular clinic visits to see if symptoms improve.
This study tests an experimental vaginal cream (AZU-101) for postmenopausal women who have vaginal dryness and pain during sex. The goal is to see if it can improve these symptoms without the risks of hormone treatments.
This study tests an oral product to see if it can help with menopause symptoms like hot flashes. It is for women aged 40–65 who still have a uterus and are not on hormone therapy.
Hear when a new Hypoactive Sexual Desire Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.